From January 2024 and June 2025, the U.S. Food and Drug Administration (FDA) approved 39 in-vitro toxicology testing products through the 510(k). This period marked a significant reshaping of the global market: Chinese companies, driven by rapid product iteration and precise market positioning, surged in the market share. At the same time, the worsening fentanyl crisis in the U.S. fueled an unprecedented demand for fentanyl testing, making it the most competitive and dynamic segment in the field.

Conventional thrombosis and hemostasis diagnostic applications are mainly concentrated on screening for bleeding disorders and diagnosis of bleeding origins, with a relatively narrow scope of application and relatively poor accuracy.

PerkinElmer reported after the close of the market on Wednesday that its second quarter revenues grew 29 percent year over year as the company beat analyst estimates on the top and bottom lines. For the three months ended July 1, 2018, Perki

IDEX Health Science, LLC (IHS) today announced the acquisition of Lima, NY based Finger Lakes Instrumentation, LLC (FLI). Finger Lakes Instrumentation is a technology leader in the design, development and production of low-noise cooled CCD a

NEW YORK (GenomeWeb) Bruker said on Thursday that it has acquired Berlin-based JPK Instruments for an undisclosed amount. JPK provides microscopy instrumentation for biomolecular and cellular imaging, as well as force measurements on single

Abbott recently said that its Diagnostics business revenues grew 47 percent year over year in the second quarter, driven by sales in its rapid diagnostics business, which reflect results for Alere acquired in October 2017. On an organic bas

Thermo Fisher Scientific recentlyreported a 22 percent increase in second-quarter revenues that was partly driven by acquisitions and increased its revenue and earnings guidance for the year for the second time in a row. We achieved excellen

Recently, Agilent Technologies announced that it has completed the acquisition of ULTRA Scientifics business assets, a supplier of chemical standards and certified reference materials. Agilent identifies chemical standards as a key enabling

Xiamen Spacegen, a provider of oncology molecular diagnostics products and services in China, said recentlythat it hadreceived CE marking for six testing kits. These kits include a human thyroid carcinoma RET gene fusions detection kit, whic

Illumina said after the close of the market recently that it intends to offer approximately $650 million of convertible senior notes due 2023. Illumina also intends to grant the initial purchasers a 30-day optionto purchase up to an addition

Finnish consumer genetic testing firm Negen has turned to BC Platforms for analysis of raw genomic data for clinical reporting purposes, the companies announced recently. Under terms of the new partnership, BC Platforms will run data collect

Bio-Rad Laboratories reported after the close of the market recently that its second quarter revenues increased 14 percent year over year, driven by growth in both its Life Science and Clinical Diagnostics businesses. For the three months e